Sevoflurane Versus Desflurane on the Incidence of Postreperfusion Syndrome During Living Donor Liver Transplantation
Authors:
- Yong-Jae YooYYYong-Jae Yoo
- Jung-Man LeeJLJung-Man Lee
- Young Jae ParkYPYoung Jae Park
- Ho Geol RyuHRHo Geol Ryu
- 1 March 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 100 (3) , 600-606
Abstract
Various interventions to reduce postreperfusion syndrome during liver transplantation have been explored, but the effect of volatile anesthetics used during liver transplantation on the incidence of postreperfusion syndrome has not been evaluated. A randomized controlled trial was performed to compare the incidence of postreperfusion syndrome between 2 commonly used volatile anesthetics, sevoflurane and desflurane. Sixty-two adult liver recipients scheduled for living-donor liver transplantation were randomized to receive either sevoflurane or desflurane for general anesthesia. The incidence of postreperfusion syndrome, use of vasoactive drugs, and postoperative course were compared. The risk factors associated with postreperfusion syndrome were also analyzed. There was significantly less postreperfusion syndrome in the sevoflurane group compared to the desflurane group (38.7% vs 77.4%, P = 0.004) and less epinephrine was required in the sevoflurane group than the desflurane group (19.4% vs 45.2%, P = 0.030). Postoperative intensive care unit and hospital length of stay and postoperative course were similar between the groups. Multivariate analysis identified desflurane (compared to sevoflurane) as the only risk factor (odds ratio 7.314, P = 0.001) for reperfusion syndrome. When using volatile anesthetics for elective living donor liver transplantation, sevoflurane seems to be a better option than desflurane for reducing the incidence of postreperfusion syndrome.Keywords
This publication has 18 references indexed in Scilit:
- Postreperfusion syndrome during orthotopic liver transplantation: a single-center experienceHepatobiliary & Pancreatic Diseases International, 2012
- Nafamostat Mesilate Attenuates Postreperfusion Syndrome during Liver TransplantationAmerican Journal of Transplantation, 2011
- The occurrence of postreperfusion syndrome in orthotopic liver transplantation and its significance in terms of complications and short-term survivalAnnals of Transplantation, 2011
- Desflurane Versus Sevoflurane for Maintenance of Outpatient Anesthesia: The Effect on Early Versus Late Recovery and Perioperative CoughingAnesthesia & Analgesia, 2009
- Postreperfusion syndrome during liver transplantation for cirrhosis: Outcome and predictorsLiver Transplantation, 2009
- The Impact of Postreperfusion Syndrome on Short-Term Patient and Liver Allograft Outcome in Patients Undergoing Orthotopic Liver TransplantationLiver Transplantation, 2008
- Faster wash-out and recovery for desflurane vs sevoflurane in morbidly obese patients when no premedication is usedBritish Journal of Anaesthesia, 2007
- Fast-track anaesthesia for laparoscopic cholecystectomyEuropean Journal of Anaesthesiology, 2006
- Role of the bradykinin B2 receptor for the local and systemic inflammatory response that follows severe reperfusion injuryBritish Journal of Pharmacology, 2003
- Postreperfusion syndrome: Hypotension after reperfusion of the transplanted liverJournal of Critical Care, 1993